The disproportionate impact of coronavirus-2019 (COVID-19) on communities of color is gaining global attention. Current research demonstrates that historically marginalized populations are experiencing disproportionate levels of SARS-Cov-2 infection and adverse clinical outcomes. However, research examining whether COVID-19 outcomes vary by race and ethnicity within the rheumatic disease population is limited. This paper will review data showing how SARS-CoV-2 infection has differentially affected racial and ethnic minorities in the general population and those with rheumatic disease. We will also highlight disparities in rheumatic disease risk and severity that existed prior to the pandemic, and discuss recent work examining severe outcomes of COVID-19 in rheumatic disease patients by race and ethnicity. Finally, we propose several actionable steps for the rheumatology community to address COVID-19 health disparities, which may have long-term effects on patients with rheumatic disease.

Tiffany Taylor

Jinoos Yazdany

Milena A. Gianfrancesco

Best Practice & Research Clinical Rheumatology

Best Practice and Research: Clinical Rheumatology

The racial/ethnic and sociocultural aspects of the pandemic in rheumatology

Data is reviewed showing how SARS-CoV-2 infection has differentially affected racial and ethnic minorities in the general population and those with rheumatic disease and proposed several actionable steps for the rheumatology community to address COVID-19 health disparities.

Category	Quartile
医学	2
医学, 风湿病学	3

The racial/ethnic and sociocultural aspects of the pandemic in rheumatology

ivySCI AI Smartly Parses PDF, Answers Researchers' Questions, and Helps You Understand Papers in Seconds

Journal Info